Key result
Infusion of the superoxide scavenger tempol into the rostral ventrolateral medulla of hypertensive rats decreased mean arterial pressure by 19 mmHg and increased GABA release, effects that were attenuated by nitric oxide synthase inhibition.
Why the study?
Does reduction of NO-mediated GABA release in the RVLM contribute to superoxide-induced sympathoexcitation in hypertensive rats?
Does reduction of NO-mediated GABA release in the RVLM contribute to superoxide-induced sympathoexcitation in hypertensive rats?
Reduction of NO-mediated GABA release in the RVLM is partly involved in superoxide-induced sympathoexcitation in stroke-prone spontaneously hypertensive rats.
Answers are grounded in this paper and cite their sources.
Supports RVLM superoxide-NO-GABA pathway in rat sympathoexcitation; leaves open relevance to human hypertension therapy.
BACKGROUND: The rostral ventrolateral medulla (RVLM) in the brainstem is responsible for regulation of the sympathetic nervous system. In the RVLM, nitric oxide (NO)-mediated γ-amino butyric acid (GABA) is a major sympathoinhibitory amino acid neurotransmitter and superoxide is a major sympathoexcitatory factor. In this study, we investigated whether or not NO-mediated GABA release is involved in superoxide-induced sympathoexcitation in the RVLM of hypertensive rats. METHODS AND RESULTS: For our model hypertensive rats with sympathoexcitation, we used stroke-prone spontaneously hypertensive rats (SHRSP). GABA levels in the RVLM were measured by in vivo microdialysis. Microinjection of tempol, a superoxide scavenger, into the RVLM decreased arterial pressure (AP), heart rate (HR), and renal sympathetic nerve activity (RSNA) with an increase in GABA release in the RVLM. Microinjection of N(G)-monomethyl-L-arginine (L-NMMA), an NO synthase inhibitor, into the RVLM increased AP, HR, and RSNA with a decrease in GABA release in the RVLM. Prior microinjection of L-NMMA into the RVLM attenuated the tempol-induced changes in AP, HR, RSNA, and GABA release in the RVLM. Microinjection of bicuculline, a GABA receptor blocker, into the RVLM attenuated the tempol- and L-NMMA-induced changes in AP, HR, and RSNA. CONCLUSIONS: The findings suggest that reduction of NO-mediated GABA release in the RVLM is partly involved in superoxide-induced sympathoexcitation of SHRSP.
No takes yet. Share an insight, caveat, or question.
Shinohara et al. (2012) studied Hypertension. Tempol (superoxide scavenger) vs. Baseline / L-NMMA pre-treatment was evaluated on Change in mean arterial pressure (MAP) (p=<0.01). Infusion of the superoxide scavenger tempol into the rostral ventrolateral medulla of hypertensive rats decreased mean arterial pressure by 19 mmHg and increased GABA release, effects that were attenuated by nitric oxide synthase inhibition.
Synapse has enriched 10 related papers. Consider them for comparative context: